BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

Rehmann Capital Advisory Group's Holding History (CIK: 0001633037)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 10,141 Value ($000) $77 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 10,141 Value ($000) $91 Avg Close $9.31 Range $6.02 - $11.31
Q1 2025
Shares 11,516 Value ($000) $86 Avg Close $8.07 Range $6.96 - $9.50
Q4 2024
Shares 11,516 Value ($000) $87 Avg Close $7.59 Range $6.85 - $8.44
Q3 2024
Shares 11,966 Value ($000) $91 Avg Close $7.60 Range $6.17 - $8.88
Q2 2024
Shares 11,999 Value ($000) $74 Avg Close $5.52 Range $4.03 - $6.99
Q1 2024
Shares 12,074 Value ($000) $61 Avg Close $5.62 Range $4.82 - $7.75
Q4 2023
Shares 12,074 Value ($000) $72 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 12,141 Value ($000) $86 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 12,141 Value ($000) $85 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 12,141 Value ($000) $101 Avg Close $9.63 Range $7.82 - $12.08
Q4 2022
Shares 12,141 Value ($000) $139 Avg Close $12.47 Range $10.36 - $14.50
Q3 2022
Shares 12,141 Value ($000) $152,976 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 12,141 Value ($000) $128,451 Avg Close $10.32 Range $7.61 - $18.00
Q1 2022
Shares 12,141 Value ($000) $197,412 Avg Close $16.04 Range $11.56 - $19.99
Q4 2021
Shares 12,141 Value ($000) $168,152 Avg Close $13.23 Range $10.72 - $15.77